TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 4 | 16 | 17 | -1 | 67 | -31 | 12 |
| P | %wins | 100 | 100 | 100 | 67 | 100 | 33 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/19/11 09:45 | 1/18/11 | BPAX | Biosante Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Simes Stephen M | IL | DO | Vice CB, | P | 9 | 1.77 | 4 | 5 | 3 | 202 | I | 14 | 7 | 11 | 8 | 27 | 13 | 7 | 6 | 5 | 8 | 16 | 16 | 104 | -63 |
1/5/09 10:04 | 1/2/09 | BPAX | Biosante Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Simes Stephen M | IL | DO | Vice CB, | P | 11 | 1.09 | 0 | 10 | 5 | 197 | I | -58 | -69 | -73 | -72 | -33 | -26 | -17 | 2 | 7 | 28 | 32 | 19 | 53 | 31 |
12/17/07 10:05 | 12/14/07 | BPAX | Biosante Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Simes Stephen M | IL | DO | Vice Cha | P | 37 | 3.70 | 0 | 10 | 6 | 187 | I | -7 | 30 | -45 | -38 | -35 | -22 | -10 | -1 | 1 | 12 | 3 | -39 | 44 | -60 |
8/6/03 17:49 | 8/4/03 | BISP | Biosante Pharmaceuticals Inc | WY | Health | BioPrd | Biological Products, (No Diag | Simes Stephen M | IL | DO | Vice CB, | P.d | 2 | 2.15 | 0 | 1 | 2 | 64 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |